DEFA14A: CACI Amends Incentive Plan After ISS Criticism

CACI International Inc revised its 2025 Incentive Compensation Plan, removing 200,000 new shares, to address Institutional Shareholder Services' negative recommendation ahead of its Annual Meeting.

Summary

• CACI International Inc filed a supplement to its definitive proxy statement for the 2025 Annual Meeting of Shareholders, scheduled for October 16, 2025.
• The supplement provides updated information regarding Proposal 3, which seeks approval for the 2025 Incentive Compensation Plan (the '2025 Plan').
• Institutional Shareholder Services Inc. (ISS) had recommended a vote against Proposal 3, citing that the shareholder value transfer (SVT) exceeded applicable ISS SVT benchmarks.
• In response to ISS's concerns, the Compensation Committee of the Board of Directors amended the 2025 Plan.
• The amendment eliminates the addition of 200,000 new shares that were initially proposed to be available for issuance under the 2025 Plan.
• As a result of the amendment, the shares available for issuance will now consist only of shares remaining from the existing 2016 Amended and Restated Incentive Compensation Plan and any shares from outstanding 2016 Plan awards that expire, terminate, or are forfeited after the 2025 Plan's effective date.
• The company assures shareholders that the 2025 Plan, as amended, will not increase potential dilution, with the overhang remaining unchanged at approximately 5.35% (based on shares outstanding as of August 29, 2025).
• The Board of Directors continues to recommend that shareholders vote FOR approval of Proposal 3.

Sentiment

Score: 7

Explanation: The company demonstrated good corporate governance by responding to a significant negative recommendation from a key proxy advisor and amending its incentive plan. This proactive adjustment to address shareholder concerns is a positive step, although the initial plan's design requiring such an amendment prevents a higher score.

Positives

• The company proactively addressed concerns raised by Institutional Shareholder Services (ISS) regarding the 2025 Incentive Compensation Plan.
• The amendment to remove 200,000 new shares from the plan demonstrates responsiveness to shareholder advisory firm feedback.
• Potential dilution (overhang) remains unchanged at approximately 5.35%, mitigating concerns about excessive shareholder value transfer.

Negatives

• The initial design of the 2025 Incentive Compensation Plan drew a negative recommendation from ISS due to exceeding shareholder value transfer benchmarks, indicating a potential misalignment with proxy advisor expectations.
• The need for an amendment suggests the initial proposal may not have been optimally structured to gain broad shareholder support without modification.

Risks

• Risk of shareholder dissent if the amended plan is still perceived as not fully addressing concerns about executive compensation or dilution, although the company has taken steps to mitigate this.
• General risks associated with equity compensation plans, including potential dilution if not managed effectively, and the need for ongoing alignment of incentives with long-term shareholder value.

Future Outlook

The 2025 Incentive Compensation Plan, as amended, is designed to promote the long-term growth and profitability of the company by providing incentives to eligible individuals to improve stockholder value and contribute to financial success, as well as to attract, retain, and reward top talent.

Management Comments

• "Your Vote is Important: Please Vote FOR Proposal 3."
• "THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE FOR APPROVAL OF PROPOSAL 3."

Industry Context

Equity compensation plans are a standard practice in the U.S. public company landscape, crucial for aligning management and employee incentives with shareholder interests. Proxy advisory firms like ISS play a significant role in corporate governance, influencing shareholder votes on such proposals by evaluating them against industry benchmarks for dilution and shareholder value transfer. CACI's amendment reflects a common practice of companies adjusting proposals in response to proxy advisor recommendations to secure shareholder approval.

Comparison to Industry Standards

• The initial 2025 Incentive Compensation Plan exceeded Institutional Shareholder Services' (ISS) shareholder value transfer (SVT) benchmarks, indicating it was less favorable to shareholders compared to what ISS typically recommends for similar companies.
• The amendment to remove 200,000 new shares from the plan brings the proposal closer to industry best practices and proxy advisor guidelines, as it directly addresses the concern regarding excessive SVT and maintains the potential dilution (overhang) at a level deemed acceptable by the company (5.35%).

Corporate Governance

Stakeholder Impact

• Shareholders: Benefit from reduced potential dilution compared to the original proposal and improved corporate governance practices through the company's responsiveness to proxy advisor feedback.
• Employees and Management: Will continue to have access to equity incentives under the amended 2025 Plan, which aims to attract, retain, and motivate talent, albeit with a slightly smaller pool of new shares than initially contemplated.

Next Steps

• Shareholders are encouraged to vote on Proposal 3 at the 2025 Annual Meeting of Shareholders on October 16, 2025.
• If approved, the 2025 Incentive Compensation Plan will become effective on October 16, 2025.

Key Dates

Recommendation

The company's proactive amendment of its incentive compensation plan in response to proxy advisor concerns is a positive governance development. It mitigates a potential negative factor (excessive dilution/SVT) but does not introduce new fundamental catalysts for the company's operational or financial performance. Therefore, it reinforces a 'hold' position for investors, as it addresses a governance issue without significantly altering the investment thesis.

Keywords

CACI International, Incentive Compensation Plan, Proxy Statement, Shareholder Meeting, ISS, Equity Compensation, Stock Options, Restricted Stock, Corporate Governance, Shareholder Value Transfer, Dilution